Stock comparison

ABBVvsUTHR

AbbVie IncvsUnited Therapeutics Corp. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

ABBV

AbbVie Inc

$200.95

-12.05%

Biotechnology$362.8BNYSE

UTHR

United Therapeutics Corp

$572.85

+15.96%

Biotechnology$23.1BNASDAQ

60-day price, rebased to 100

ABBV -8.25% · UTHR +22.59%

Round-by-round

ABBV 1·UTHR 4· 1tie

EdgeUTHR

Valuation upside

-48.60% vs -10.40% to DCF fair value

EdgeUTHR

Balance-sheet strength

Altman Z 2.25 vs 20.69

Tie

Fundamental quality

Piotroski 7.00 vs 7.00 (of 9)

EdgeUTHR

Growth + margins

Rule-of-40 37.70 vs 43.10

EdgeUTHR

60-day momentum

-8.25% vs +22.59% price return

EdgeABBV

Market-cap liquidity

$362.8B vs $23.1B

Verdict

Across6categories,UTHRtakes the edge with4wins to1 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onABBVorUTHR

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.